Jonsson Comprehensive Cancer Center
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients with Resectable Brain Tumors
- Conditions
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06650163
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)
- Conditions
- Interventions
- Procedure: Personalized ultrafractionated stereotactic adaptive radiotherapyRadiation: Volume Modulated Arc TherapyProcedure: Computed TomographyProcedure: Positron Emission TomographyProcedure: Magnetic Resonance ImagingOther: Best PracticeBehavioral: University of Washington Quality of Life Scale, Version 4Behavioral: Functional Assessment of Cancer Therapy-Head & Neck
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT06572423
- Locations
- 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
- Conditions
- Interventions
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 1500
- Registration Number
- NCT06568016
- Locations
- 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
🇺🇸UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT06543576
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸University of California San Diego (UCSD), San Diego, California, United States
🇺🇸University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
- Conditions
- Interventions
- First Posted Date
- 2024-08-05
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06538337
- Locations
- 🇺🇸
University of California at Los Angeles, Los Angeles, California, United States
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
- Conditions
- Interventions
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06448286
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-06-06
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 91
- Registration Number
- NCT06447103
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)
- Conditions
- Interventions
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06436612
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
- Conditions
- Interventions
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT06432036
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT06387173
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States